| Patent | Date |
|---|
Use Of Ouabain Antagonists To Inhibit Viral Infection
App 20220249518 - Collins; Peter L. ; et al. | 2022-08-11 |
Recombinant Chimeric Bovine/human Parainfluenza Virus 3 Expressing Rsv G And Its Use
App 20220226458 - Collins; Peter L. ; et al. | 2022-07-21 |
Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes
Grant 11,390,651 - Lenouen , et al. July 19, 2 | 2022-07-19 |
Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization
Grant 11,371,024 - Collins , et al. June 28, 2 | 2022-06-28 |
Recombinant respiratory syncytial virus strains with mutations in the M2-2 ORF providing a range of attenuation phenotypes
Grant 11,332,721 - Collins , et al. May 17, 2 | 2022-05-17 |
Recombinant chimeric bovine/human parainfluenza virus 3 expressing RSV G and its use
Grant 11,273,214 - Collins , et al. March 15, 2 | 2022-03-15 |
Genetically Stable Live Attenuated Respiratory Syncytial Virus Vaccine And Its Production
App 20210330782 - Collins; Peter L. ; et al. | 2021-10-28 |
Vaccine Candidates For Human Respiratory Syncytial Virus (rsv) Having Attenuated Phenotypes
App 20210188920 - LENOUEN; Cyril ; et al. | 2021-06-24 |
Chimeric Vectors
App 20210189425 - Munir; Shirin ; et al. | 2021-06-24 |
Recombinant Respiratory Syncytial Virus Strains Comprising Ns1 And Ns2 Gene Shifts
App 20210177960 - Collins; Peter L. ; et al. | 2021-06-17 |
Recombinant Chimeric Bovine/human Parainfluenza Virus 3 Expressing Rsv G And Its Use
App 20210145958 - Collins; Peter L. ; et al. | 2021-05-20 |
Genetically stable live attenuated respiratory syncytial virus vaccine and its production
Grant 10,980,872 - Collins , et al. April 20, 2 | 2021-04-20 |
Recombinant respiratory syncytial virus strains comprising NS1 and NS2 gene shifts
Grant 10,953,083 - Collins , et al. March 23, 2 | 2021-03-23 |
Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes
Grant 10,808,012 - Lenouen , et al. October 20, 2 | 2020-10-20 |
Recombinant Respiratory Syncytial Virus Strains With Mutations In The M2-2 Orf Providing A Range Of Attenuation Phenotypes
App 20200283740 - Collins; Peter L. ; et al. | 2020-09-10 |
Recombinant respiratory syncytial virus stains with mutations in the M2-2 ORF providing a range of attenuation phenotypes
Grant 10,655,109 - Collins , et al. | 2020-05-19 |
Genetically Stable Live Attenuated Respiratory Syncytial Virus Vaccine And Its Production
App 20190282690 - Collins; Peter L. ; et al. | 2019-09-19 |
Vaccine Candidates For Human Respiratory Syncytial Virus (rsv) Having Attenuated Phenotypes
App 20190233476 - LENOUEN; Cyril ; et al. | 2019-08-01 |
Recombinant Respiratory Syncytial Virus Strains Comprising Ns1 And Ns2 Gene Shifts
App 20190184000 - Collins; Peter L. ; et al. | 2019-06-20 |
Genetically stable live attenuated respiratory syncytial virus vaccine and its production
Grant 10,307,476 - Collins , et al. | 2019-06-04 |
Recombinant Respiratory Syncytial Virus Strains With Mutations In The M2-2 Orf Providing A Range Of Attenuation Phenotypes
App 20190040365 - Collins; Peter L. ; et al. | 2019-02-07 |
Method Of Vaccination With An Attenuated Rsv Vaccine Formulation
App 20180318411 - COLLINS; Peter L. ; et al. | 2018-11-08 |
Attenuation Of Human Respiratory Syncytial Virus By Genome Scale Codon-pair Deoptimization
App 20180208906 - Collins; Peter L. ; et al. | 2018-07-26 |
Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization
Grant 9,957,486 - Collins , et al. May 1, 2 | 2018-05-01 |
Genomic sequence of avian paramyxovirus type 2 and uses thereof
Grant 9,937,196 - Samal , et al. April 10, 2 | 2018-04-10 |
Genetically Stable Live Attenuated Respiratory Syncytial Virus Vaccine And Its Production
App 20170189520 - Collins; Peter L. ; et al. | 2017-07-06 |
Genetically stable live attenuated respiratory syncytial virus vaccine and its production
Grant 9,624,475 - Collins , et al. April 18, 2 | 2017-04-18 |
Attenuation Of Human Respiratory Syncytial Virus By Genome Scale Codon-pair Deoptimization
App 20150368622 - Collins; Peter L. ; et al. | 2015-12-24 |
Attenuated human parainfluenza virus, methods and uses thereof
Grant 9,034,343 - Skiadopoulos , et al. May 19, 2 | 2015-05-19 |
Genetically Stable Live Attenuated Respiratory Syncytial Virus Vaccine And Its Production
App 20150118732 - Collins; Peter L. ; et al. | 2015-04-30 |
Attenuated Human Parainfluenza Virus, Methods And Uses Thereof
App 20130052718 - Skiadopoulos; Mario H. ; et al. | 2013-02-28 |
Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
Grant 8,367,074 - Skiadopoulos , et al. February 5, 2 | 2013-02-05 |
Recovery Of Recombinant Human Parainfluenza Virus Type 2 (hypiv2) From Cdna And Use Of Recombinant Hpiv2 In Immunogenic Compositions And As Vectors To Elicit Immune Responses Against Piv And Other Human Pathogens
App 20130023030 - SKIADOPOULOS; Mario H. ; et al. | 2013-01-24 |
Production Of Attenuated Negative Stranded Rna Virus Vaccines From Cloned Nucleotide Sequences
App 20120064569 - Murphy; Brian R. ; et al. | 2012-03-15 |
Genomic sequence of avian paramyxovirus type 2 and uses thereof
App 20110217266 - Samal; Siba K. ; et al. | 2011-09-08 |
RECOMBINANT HUMAN PARAINFLUENZA TYPE 1 VIRUSES (HPIV1s) CONTAINING MUTATIONS IN OR DELETION OF THE C PROTEIN ARE ATTENUATED IN AFRICAN GREEN MONKEYS AND IN CILIATED HUMAN AIRWAY EPITHELIAL CELLS AND ARE POTENTIAL VACCINE CANDIDATES FOR HPIV1
App 20110189232 - Bartlett; Emmalene ; et al. | 2011-08-04 |
Recovery Of Recombinant Human Parainfluenza Virus Type 2 (hypiv2) From Cdna And Use Of Recombinant Hpiv2 In Immunogenic Compositions And As Vectors To Elicit Immune Responses Against Piv And Other Human Pathogens
App 20110143422 - SKIADOPOULOS; Mario H. ; et al. | 2011-06-16 |
Attenuated parainfluenza virus (PIV) vaccines
Grant 7,951,383 - Murphy , et al. May 31, 2 | 2011-05-31 |
Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from CDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
Grant 7,919,301 - Skiadopoulos , et al. April 5, 2 | 2011-04-05 |
Human Parainfluenza Viruses Having Separated P And C Genes
App 20100330120 - Collins; Peter L. ; et al. | 2010-12-30 |
Attenuated chimeric respiratory syncytial virus
Grant 7,846,455 - Collins , et al. December 7, 2 | 2010-12-07 |
Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines
Grant 7,842,798 - Buchholz , et al. November 30, 2 | 2010-11-30 |
Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines
Grant 7,829,102 - Buchholz , et al. November 9, 2 | 2010-11-09 |
Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
Grant 7,820,181 - Skiadopoulos , et al. October 26, 2 | 2010-10-26 |
Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in immunogenic compositions
Grant 7,820,182 - Buchholz , et al. October 26, 2 | 2010-10-26 |
Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes
Grant 7,744,902 - Krempl , et al. June 29, 2 | 2010-06-29 |
Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
Grant 7,709,007 - Murphy , et al. May 4, 2 | 2010-05-04 |
Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of recombinant HPIV1 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
Grant 7,704,509 - Murphy , et al. April 27, 2 | 2010-04-27 |
Recombinant human metapneumovirus and its use
Grant 7,704,491 - Collins , et al. April 27, 2 | 2010-04-27 |
Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes
Grant 7,662,397 - Krempl , et al. February 16, 2 | 2010-02-16 |
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
Grant 7,632,508 - Schmidt , et al. December 15, 2 | 2009-12-15 |
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
Grant 7,622,123 - Skiadopoulos , et al. November 24, 2 | 2009-11-24 |
Negative strand RNA virus replicon
Grant 7,585,667 - Olivo , et al. September 8, 2 | 2009-09-08 |
Production Of Attenuated Negative Stranded Rna Virus Vaccines From Cloned Nucleotide Sequences
App 20090081728 - Murphy; Brian R. ; et al. | 2009-03-26 |
Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2
Grant 7,485,440 - Collins , et al. February 3, 2 | 2009-02-03 |
Polynucleotides encoding recombinant respiratory syncytial viruses expressing immune modulatory molecules
Grant 7,465,794 - Collins , et al. December 16, 2 | 2008-12-16 |
RECOVERY OF RECOMBINANT HUMAN PARAINFLUENZA VIRUS TYPE 2 (HPIV2) FROM cDNA AND USE OF RECOMBINANT HPIV2 IN IMMUNOGENIC COMPOSITIONS AND AS VECTORS TO ELICIT IMMUNE RESPONSES AGAINST PIV AND OTHER HUMAN PATHOGENS
App 20080286848 - SKIADOPOULOS; Mario H. ; et al. | 2008-11-20 |
Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2
App 20080138861 - Collins; Peter L. ; et al. | 2008-06-12 |
Attenuated parainfluenza virus (PIV) vaccines
App 20080096264 - Murphy; Brian R. ; et al. | 2008-04-24 |
Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect against disease caused by PIV and respiratory syncytial virus (RSV)
Grant 7,314,631 - Murphy , et al. January 1, 2 | 2008-01-01 |
Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines
App 20070184069 - Buchholz; Ursula ; et al. | 2007-08-09 |
Construction and use of recombinant parainfluenza viruses expressing a chimeric glycoprotein
Grant 7,250,171 - Tao , et al. July 31, 2 | 2007-07-31 |
Production of novel Newcastle disease virus strains from cDNAs and improved live attenuated Newcastle disease vaccines
Grant 7,244,558 - Samal , et al. July 17, 2 | 2007-07-17 |
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
App 20070134271 - Skiadopoulos; Mario H. ; et al. | 2007-06-14 |
Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences
Grant 7,208,161 - Murphy , et al. April 24, 2 | 2007-04-24 |
Attenuated human-bovine chimeric parainfluenza virus(PIV) vaccines
Grant 7,201,907 - Schmidt , et al. April 10, 2 | 2007-04-10 |
Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens
Grant 7,192,593 - Murphy , et al. March 20, 2 | 2007-03-20 |
Negative strand rna virus replicon
App 20060275774 - Olivo; Paul D. ; et al. | 2006-12-07 |
Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
App 20060159703 - Murphy; Brian R. ; et al. | 2006-07-20 |
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
App 20060099226 - Schmidt; Alexander C. ; et al. | 2006-05-11 |
Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines
App 20060057158 - Buchholz; Ursula ; et al. | 2006-03-16 |
Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes
App 20060024797 - Krempl; Christine D. ; et al. | 2006-02-02 |
Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes
App 20060018927 - Krempl; Christine D. ; et al. | 2006-01-26 |
Production of attenuated negative stranded RNA virus vaccines from cloned nucleotide sequences
App 20050287540 - Murphy, Brian R. ; et al. | 2005-12-29 |
Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules
App 20050220767 - Collins, Peter L. ; et al. | 2005-10-06 |
Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes
Grant 6,923,971 - Krempl , et al. August 2, 2 | 2005-08-02 |
Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in immunogenic compositions
App 20050158338 - Buchholz, Ursula ; et al. | 2005-07-21 |
Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules
App 20050147622 - Collins, Peter L. ; et al. | 2005-07-07 |
Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
App 20050100557 - Collins, Peter L. ; et al. | 2005-05-12 |
Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes
App 20040258714 - Krempl, Christine D. ; et al. | 2004-12-23 |
Recombinant human metapneumovirus and its use
App 20040241188 - Collins, Peter L. ; et al. | 2004-12-02 |
Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immonogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
App 20040204581 - Skiadopoulos, Mario H. ; et al. | 2004-10-14 |
Methods for producing self-replicating infectious RSV particles comprising recombinant RSV genomes or antigenomes and the N, P, L, and M2 proteins
Grant 6,790,449 - Collins September 14, 2 | 2004-09-14 |
Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of recombinant HPIV1 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
App 20040142448 - Murphy, Brian R. ; et al. | 2004-07-22 |
Production of attenuated respiratory syncytial virus vaccines involving modification of M2 ORF2
Grant 6,713,066 - Collins , et al. March 30, 2 | 2004-03-30 |
Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules
Grant 6,699,476 - Collins , et al. March 2, 2 | 2004-03-02 |
Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
Grant 6,689,367 - Collins , et al. February 10, 2 | 2004-02-10 |
Respiratory syncytial virus vaccines expressing protective antigens from promotor- proximal genes
App 20040005542 - Krempl, Christine D ; et al. | 2004-01-08 |
Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
App 20030082209 - Skiadopoulos, Mario H. ; et al. | 2003-05-01 |
Methods for producing self-replicating infectious RSV particles comprising recombinant RSV genomes or antigenomes and the N, P, L, and M2 proteins
App 20020182228 - Collins, Peter L. | 2002-12-05 |
Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens
App 20020155581 - Murphy, Brian R. ; et al. | 2002-10-24 |
Respiratory syncytial virus vaccines expressing protective antigens from promoter-proximal genes
App 20020146433 - Krempl, Christine D. ; et al. | 2002-10-10 |
Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene
Grant 6,410,023 - Durbin , et al. June 25, 2 | 2002-06-25 |
Product of infectious respiratory syncytial virus from cloned nucleotide sequences
Grant 6,264,957 - Collins July 24, 2 | 2001-07-24 |
Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
Grant 5,993,824 - Murphy , et al. November 30, 1 | 1999-11-30 |
Vaccines for human respiratory virus
Grant 5,149,650 - Wertz , et al. September 22, 1 | 1992-09-22 |
| 